Clinical trials: sponsored by Oslo University Hospital
Cerebral Hemorrhage, Intracranial Hemorrhages
Study of Antithrombotic Treatment After IntraCerebral Haemorrhage
The study evaluates the effects of antithrombotic drugs (anticoagulant drugs or antiplatelet drugs) for prevention of ischaemic events in patients With recent intracerebral haemorrhage.
- Conditions
- Cerebral Hemorrhage, Intracranial Hemorrhages, Atrial Fibrillation, Anticoagulant-Induced Bleeding
- Trial name
- STATICH (NCT03186729)
- Testing
- Antithrombotic Agent
- Where
- 3 sites in Denmark, Norway and 1 more
- Volunteers
- 134 people
- Sponsor
- Oslo University Hospital
Schizophrenic Psychoses, Schizophrenia
Implementation of a Tool for Reduction of Cardiovascular Risk in Patients with Severe Mental Disorders ( HEALTHYHEART )
Observational study of the implementation of a Norwegian adaptation of a tool for monitoring, detection and intervention of cardiovascular risk factors in severe mental disorders.
- Conditions
- Schizophrenic Psychoses, Schizophrenia, Severe Mental Disorder
- Trial name
- HEALTHYHEART (NCT06807242)
- Where
- Norway
- Volunteers
- 270 people
- Sponsor
- Oslo University Hospital
Cervical Cancer
Altered Tumor Oxygenation by Metformin, a Potential Step in Overcoming Radiotherapy Resistance in LACC
Poor tumor oxygenation (hypoxia) is an established negative prognostic and predictive factor in locally advanced cervical cancer (LACC). Hypoxia-modifying measures implemented in the clinic are lacking.
- Trial name
- METOXY-LACC (NCT04275713)
- Testing
- Metformin, Cisplatin
- Where
- Norway
- Volunteers
- 41 people
- Sponsor
- Oslo University Hospital
Metabolic Syndrome
Effects of Cetoleic Acid on Atherosclerosis (Ketolinsyre's Effekt på Aterosklerose)
In this Randomized Controlled Trial (RCT) we want to study the effect of an oil with high concentrations of cetoelic acid (C22:n1-11) (intervention) compared to supplements with a low concentration of cetoleic acid (control), but…
- Trial name
- NCT06172335
- Testing
- Cetoleic acid, Control oil
- Where
- Norway
- Volunteers
- 70 people
- Sponsor
- Oslo University Hospital
Prostate Cancer
Preoperative PSMA PET/CT As Triage for EPLND in Patients Scheduled for RALP (PrePSMA)
Extended pelvic lymph node dissection (ePLND) is considered the gold standard for nodal staging in men with prostate cancer (PCa).
- Trial name
- PrePSMA (NCT06398613)
- Testing
- extended pelvic lymph node dissection (ePLND)
- Where
- Norway
- Volunteers
- 600 people, healthy volunteers welcome
- Sponsor
- Oslo University Hospital
Interstitial Lung Disease with Progressive Fibrotic Phenotype in Diseases Classified Elsewhere, Systemic Sclerosis Pulmonary
Home Based Clinical Management of Interstitial Lung Disease in Systemic Rheumatic Diseases
The RMD-mILDer trial is a home monitoring strategy trial aiming to improve management of interstitial lung disease related to rheumatic diseases applying eHealth technology.
- Conditions
- Interstitial Lung Disease with Progressive Fibrotic Phenotype in Diseases Classified Elsewhere, Systemic Sclerosis Pulmonary, Dermatomyositis, Rheumatoid Arthritis
- Trial name
- RMD-mILDer (NCT06732674)
- Testing
- A home monitoring strategy with event driven management
- Where
- Norway
- Volunteers
- 218 people
- Sponsor
- Oslo University Hospital
Cervical Radiculopathy
Cervical Radiculopathy Trial
The primary aim of the present project is to compare the effectiveness of surgery and nonsurgical treatment in patients with cervical radiculopathy caused by either disc herniation or spondylosis.
- Trial name
- CRT (NCT03674619)
- Testing
- Anterior discectomy, Conservative treatment
- Where
- Norway
- Volunteers
- 180 people, healthy volunteers welcome
- Sponsor
- Oslo University Hospital
Head and Neck Cancer
ReIrradiation With FDG-PET Guided Dose Painting
Dose-painting may increase the chance of cure at minimised radiation-induced toxicity in intensity-modulated radiotherapy (IMRT) for primary head and neck cancer.
- Trial name
- RIDPAINT (NCT02921581)
- Testing
- FDG-PET guided dose painting
- Where
- Norway
- Volunteers
- 10 people
- Sponsor
- Oslo University Hospital
Head and Neck Cancer
RAdiotherapy With FDG-PET Guided Dose-PAINTing for Primary Head and Neck
Dose-painting may increase the chance of cure at minimised radiation-induced toxicity in volumetric-arc radiotherapy (VMAT) for head and neck cancer.
- Trial name
- RADPAINT-2 (NCT04910308)
- Testing
- FDG-PET guided dose painting
- Where
- Norway
- Volunteers
- 10 people
- Sponsor
- Oslo University Hospital
Relapsing Multiple Sclerosis, Multiple Sclerosis
Norwegian Study of Oral Cladribine and Rituximab in Multiple Sclerosis (NOR-MS)
The main aim and overall objective of the study is to assess whether rituximab is non-inferior to cladribine for the treatment of relapsing MS.
- Trial name
- NOR-MS (NCT04121403)
- Testing
- Rituximab, Cladribine
- Where
- 11 sites in Norway
- Volunteers
- 267 people
- Sponsor
- Oslo University Hospital
Depressive Disorder, Emotional Dysregulation
Music Therapy for Adolescents with Emotional Difficulties
The goal of this clinical trial is to examine the effects of a music therapy program in adolescents aged 13-18 years old with emotional difficulties, primarily depression and possibly concurrent diagnoses of anxiety.
- Trial name
- NCT06733883
- Testing
- psychotherapy
- Where
- Norway
- Volunteers
- 20 people
- Sponsor
- Oslo University Hospital
Venous Malformation, Low Flow, Anticoagulants
A Study of Direct Oral Anticoagulants in Patients with Painful Venous Malformations with Localized Intravascular Coagulation
There are two parts of the study. In Part 1, the invesitgaotrs want to investigate whether treatment with apixaban improves pain and quality of life in patients with painful venous malformations The participants are randomized to…
- Trial name
- AVA (NCT06729034)
- Testing
- Apixaban (Eliquis)
- Where
- Norway
- Volunteers
- 20 people
- Sponsor
- Oslo University Hospital
Cardiorenal Syndrome, Heart Failure
Venous Ultrasound Guided Organ Decongestion in Patients Hospitalized with Acute Decompensated Heart Failure
The purpose of this study is to assess the feasibility, safety and effectiveness of VExUS guided organ decongestion compared to standard of care in patients hospitalized with acute decompensated heart failue (ADHF).
- Conditions
- Cardiorenal Syndrome, Heart Failure, Acute Kidney Injury, Acute Decompensated Heart Failure
- Trial name
- VExOUS-ADHF (NCT06714409)
- Testing
- VExUS guided decongestion
- Where
- Norway
- Volunteers
- 180 people
- Sponsor
- Oslo University Hospital
Pancreatic Cancer
Nordic Pancreatic Cancer Trial (NorPACT) - 1
This study evaluate the additional effect of adding chemotherapy prior to resection of a pancreatic head malignancy. The patients will be randomized into two groups; surgery first (control group) and neoadjuvant chemotherapy…
- Trial name
- NCT02919787
- Testing
- 5-FU, Oxaliplatine, Irinotecan
- Where
- 13 sites in Denmark, Finland and 2 more
- Volunteers
- 140 people
- Sponsor
- Oslo University Hospital
Locally Advanced Pancreatic Adenocarcinoma, Chemotherapy Effect
Neoadjuvant Chemotherapy in Borderline Resectable and Locally Advanced Pancreatic Cancer (NORPACT-2)
This is a Norwegian prospective observational study that evaluates the resectability rate in patients with borderline resectable and locally advanced pancreatic cancer who received neoadjuvant chemotherapy in a population based…
- Conditions
- Locally Advanced Pancreatic Adenocarcinoma, Chemotherapy Effect, Borderline Resectable Pancreatic Adenocarcinoma, Pancreatectomy
- Trial name
- NCT04423731
- Testing
- Folfirinox
- Where
- Norway
- Volunteers
- 251 people
- Sponsor
- Oslo University Hospital
Hepatitis B
Treatment of Hepatitis B in Resource-limited Settings - a Pilot Program in East Africa
Viral hepatitis kills nearly one million people each year, even though effective treatment exists. The aim of this study is to establish a treatment protocol for hepatitis B, which is simple and cheap enough to be implemented in…
- Trial name
- NCT02344498
- Testing
- Tenofovir disoproxil
- Where
- Ethiopia
- Volunteers
- 7,350 people
- Sponsor
- Oslo University Hospital
Olecranon Fracture
Operative Treatment of Olecranon Fractures
The incidence of olecranon fractures is 12 per 100.000. Traditionally, isolated olecranon fractures have been treated with tension band wiring (TBW).
- Trial name
- NCT03280602
- Testing
- Tension band wiring (TBW), Plate fixation
- Where
- Norway
- Volunteers
- 200 people
- Sponsor
- Oslo University Hospital
Melanoma Stage IIIB-IV
NeoLIPA: Neoadjuvant LTX-315 in Combination with Pembrolizumab in Resectable Stage III/IV Melanoma
This clinical trial aims to evaluate the effectiveness of a new treatment approach for patients with stage III or IV melanoma that has spread to other parts of the body but can still be surgically removed.
- Trial name
- NeoLIPA (NCT06651151)
- Testing
- LTX-315 + pembrolizumab
- Where
- Norway
- Volunteers
- 27 people
- Sponsor
- Oslo University Hospital
Breast Cancer, Hormone Receptor Positive Tumor
Phase IIb Study Evaluating Immunogenic Chemotherapy Combined With Ipilimumab and Nivolumab in Breast Cancer
Breast cancer is rarely curable after metastasis, and the therapeutic options are limited. Interestingly, the host immune response is strongly predictive for the effect of chemotherapy in subgroups of patients with breast cancer.
- Conditions
- Breast Cancer, Hormone Receptor Positive Tumor, Metastatic Breast Cancer
- Trial name
- ICON (NCT03409198)
- Testing
- Ipilimumab, Nivolumab, Pegylated liposomal doxorubicin
- Where
- 6 sites in Belgium, Norway
- Volunteers
- 82 people
- Sponsor
- Oslo University Hospital
Cancer, Breast, Triple Negative Breast Cancer
Atezolizumab Combined With Immunogenic Chemotherapy in Patients With Metastatic Triple-negative Breast Cancer
This is a randomized, double-blind, placebo-controlled phase II study evaluating the safety and efficacy of Atezolizumab when combined with immunogenic chemotherapy in subjects with metastatic triple-negative breast cancer.
- Trial name
- ALICE (NCT03164993)
- Testing
- Atezolizumab, Pegylated liposomal doxorubicin, Cyclophosphamide
- Where
- 5 sites in Denmark, Norway
- Volunteers
- 68 people
- Sponsor
- Oslo University Hospital